Unilife Corp. (NASDAQ: UNIS) announced they have begun supplying...

Unilife Corp. (NASDAQ: UNIS) announced they have begun supplying Sanofi with its Unifill? syringe as per the terms of their agreement.

Unilife has received a total of $40 million from Sanofi for the exclusivity of the Unifill syringe within the full therapeutic class of antithrombotic agents and vaccines in addition to four smaller subgroups up until June 2014.

The Unifill? ready-to-fill (prefilled) syringe is a primary drug container with passive (automatic) safety features fully integrated within the glass barrel. It is designed for integration into the fill-finish systems used for equivalent products, and supplied as per standard handling processes. The Unifill syringe is similar in size to an equivalent standard prefilled syringe and is significantly smaller than those supplied with an ancillary safety device. This sets Unilifes product aside from all others on the market.

http://www.einnews.com/pr-news/477773-unilife-corp-sends-out-its-first-order-to-sanofi-